| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Tectonic Therapeutic, Inc. | Chief Medical Officer | Common Stock | 49.9K | $119K | $2.38 | Feb 4, 2025 | Direct |
| Tectonic Therapeutic, Inc. | Chief Medical Officer | Employee Stock Option (Right to Buy) | 81.7K | Jun 20, 2024 | Direct | ||
| Sionna Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 39.9K | Feb 6, 2025 | Direct | ||
| Tectonic Therapeutic, Inc. | Chief Medical Officer | Employee Stock Option (Right to Buy) | 32.5K | Feb 4, 2025 | Direct | ||
| Upstream Bio, Inc. | Director | Stock Option (Right to Buy) | 17.1K | Oct 10, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SION | Sionna Therapeutics, Inc. | Feb 6, 2025 | 1 | $0 | 4 | Feb 10, 2025 | Director |
| SION | Sionna Therapeutics, Inc. | Feb 6, 2025 | 0 | $0 | 3 | Feb 6, 2025 | Director |
| TECX | Tectonic Therapeutic, Inc. | Feb 4, 2025 | 2 | $0 | 4 | Feb 6, 2025 | Chief Medical Officer |
| UPB | Upstream Bio, Inc. | Oct 10, 2024 | 1 | $0 | 4 | Oct 15, 2024 | Director |
| UPB | Upstream Bio, Inc. | Oct 10, 2024 | 0 | $0 | 3 | Oct 10, 2024 | Director |
| TECX | Tectonic Therapeutic, Inc. | Jun 20, 2024 | 4 | $0 | 4 | Jun 24, 2024 | Chief Medical Officer |
| TECX | Tectonic Therapeutic, Inc. | Jun 20, 2024 | 0 | $0 | 3 | Jun 24, 2024 | Chief Medical Officer |